Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin B Knopf

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Plos One|June 26, 2020
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemiaShamia Hoque, Brian J Chen, Martin W Schoen, et al.
Plos One|August 1, 2019
Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactionsCharles L Bennett, Benjamin Schooley, Matthew A Taylor, et al.
Nature Biomedical Engineering|March 12, 2019
Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learningMichael S Manak, Jonathan S Varsanik, Brad J Hogan, et al.
American Health & Drug Benefits|July 4, 2014
Defining Value in Cancer Care: AVBCC 2013 Steering Committee Report, Burt Zweigenhaft, Linda Bosserman, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Plos One|June 26, 2020
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemiaShamia Hoque, Brian J Chen, Martin W Schoen, et al.
Plos One|August 1, 2019
Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactionsCharles L Bennett, Benjamin Schooley, Matthew A Taylor, et al.
Nature Biomedical Engineering|March 12, 2019
Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learningMichael S Manak, Jonathan S Varsanik, Brad J Hogan, et al.
American Health & Drug Benefits|July 4, 2014
Defining Value in Cancer Care: AVBCC 2013 Steering Committee Report, Burt Zweigenhaft, Linda Bosserman, et al.
Pageof 4